Predicting response to disease modifying drugs (DMARDs) in early rheumatoid arthritis (RA)

被引：0

作者：

Scott, David L. ^{[1
]}

Kiely, Patrick ^{[2
]}

Williams, Richard ^{[3
]}

Walsh, David A. ^{[4
]}

Young, Adam ^{[5
]}

机构：

[1] Kings Coll London, London WC2R 2LS, England

[2] St George Hosp, London, England

[3] Hereford Hosp, Hereford, England

[4] City Hosp, Acad Rheumatol, Nottingham NG5 1PB, England

[5] City Hosp, St Albans, England

来源：

RHEUMATOLOGY | 2008年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：II40 / II41

页数：2

共 50 条

[1] Utilization of disease modifying antirheumatic drugs (DMARDs) among patients with rheumatoid arthritis (RA).
MacLean, CH
Park, GS
Traina, SB
Liu, HH
Hahn, BH
Paulus, HE
Kahn, KI
ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S143 - S143
[2] The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients
Khoshroo, Ahmadreza
Ramezani, Keyvan
Moghimi, Niusha
Bonakdar, Moein
Ramezani, Nazanin
INFLAMMOPHARMACOLOGY, 2023, 31 (02) : 689 - 697
[3] The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients
Ahmadreza Khoshroo
Keyvan Ramezani
Niusha Moghimi
Moein Bonakdar
Nazanin Ramezani
Inflammopharmacology, 2023, 31 : 689 - 697
[4] Facing ineffectiveness of disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA): Shall DMARDs be switched or be combined?
Schoels, M
Kapral, T
Stamm, T
Smolen, JS
Aletaha, D
ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S545 - S545
[5] Incidence and severity of laboratory abnormalities during treatment with disease modifying antirheumatic drugs (DMARDS) in patients with rheumatoid arthritis (RA).
Simon, CH
Dijkmans, BAC
Moens, HJB
Vandenbroucke, JP
Breedveld, FC
Vlieland, TPMV
ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S211 - S211
[6] TREATING EARLY RHEUMATOID ARTHRITIS (RA) INTENSIVELY: UK RHEUMATOLOGISTS VIEWS AND USE OF COMBINATION DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS)
Garrood, Toby
Shattles, Warren
Scott, David L.
RHEUMATOLOGY, 2009, 48 : I83 - I83
[7] EFFICIENCY OF NON-BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH COMORBIDITY
Mykytenko, G.
Iaremenko, O.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 212 - 213
[8] Predictive factors for withdrawal of disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA): Is age relevant?
Mok, CC
Ng, WL
Yim, CW
Wong, RWS
ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S172 - S172
[9] A meta-analysis of the efficacy and toxicity of combining disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA).
Choy, EHS
Smith, C
Scott, DL
ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S170 - S170
[10] Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?
Cannella, AC
O'Dell, JR
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (03) : 185 - 192

← 1 2 3 4 5 →